ClinicalTrials.Veeva

Menu

Registry for Hirschsprung Disease of the BELAPS

U

Universitaire Ziekenhuizen KU Leuven

Status

Enrolling

Conditions

Hirschsprung Disease

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Registry for Hirschsprung disease of the BELAPS (Belgian Association of Pediatric Surgery) Protocol Short Title/Acronym

/ Sponsor name BELAPS Principal Investigator Prof. Dr. Marc Miserez Medical condition or disease under investigation Hirschsprung's disease Purpose of clinical study To register pre-, intra- and postoperative data in order to improve surgical care to paediatric patients with Hirschsprung's disease in Belgium. Primary objective The primary objective is to evaluate defecation habits at 3.5-5.5 years after surgery. Secondary objective (s) Evaluating the long-term results and evaluate risk factors for constipation / incontinence. Study Design Prospective registry Endpoints Krickenbeck score, urinary, sexual and QoL evaluation

Enrollment

432 estimated patients

Sex

All

Ages

Under 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Hirschsprung Disease, surgery

Exclusion criteria

Trial contacts and locations

1

Loading...

Central trial contact

Colette Barle

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems